| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |